MTA Portal

The introduction of AI algorithms for image analysis in radiology promises a revolution in speed and accuracy. However, clinical implementation often faces a fundamental challenge: how do you quantitatively validate the output of these 'black box' systems against real-world clinical practice? This article describes how the MTA Portal Central platform bridges this gap through direct interoperability with PACS systems.

Traditional validation studies are labor-intensive and rely on manual annotations. Our architecture enables researchers to automatically link retrospective patient cohorts. AI software can directly query the platform, retrieving relevant CT and MRI studies along with associated clinical outcome data from the EMR. This creates a closed validation loop.

Automated data extraction from PACS for AI validation.

The Validation Pipeline

Our standard defines a standardized pipeline:

Data Acquisition: The platform retrieves anonymized DICOM images from multiple hospital PACS, based on predefined inclusion criteria (e.g., "CT thorax, contrast, lung cancer").
AI Inference: The external AI algorithm processes the images and returns structured findings (e.g., tumor size, density, radiomics features) in a standardized JSON format.
Ground Truth Linkage: The platform automatically links these findings to the final pathology reports and survival data from the EMR, which serve as the ground truth.
Statistical Analysis: Performance metrics such as sensitivity, specificity, and AUC are automatically calculated and presented in a dashboard for the researcher.

A practical case study at two academic centers showed that an algorithm for detecting lung nodules on CT achieved high sensitivity (94%) in controlled test datasets, but this dropped to 87% in real, heterogeneous clinical data. This 'performance gap' only became visible through the direct PACS integration.

Implications for Medical Technology Assessment

This approach shifts the MTA focus from potential to validated clinical effectiveness. Hospitals can make evidence-based decisions about purchasing AI software. Developers gain access to scalable validation infrastructure. The next phase is integrating real-time monitoring of algorithm performance after implementation.

The interoperability standards of MTA Portal Central thus form the backbone for a new generation of transparent and quantitatively substantiated medical image analysis.